Vibrant Group Limited (SGX:BIP)

Sage Therapeutics Ratios and Metrics

Market cap in millions SGD. Fiscal year is May - April.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 11, 2025	Apr 30, 2025	Apr 30, 2024	Apr 30, 2023	Apr 30, 2022	Apr 30, 2021
Market Capitalization	107	56	43	49	62	71
Market Cap Growth	31.00%	31.00%	-11.85%	-21.54%	-12.62%	9.57%
Enterprise Value	214	174	173	192	239	236
Last Close Price	0.16	0.08	0.06	0.07	0.08	0.10
PE Ratio	13.91	7.34	71.84	279.42	6.71	22.65
PS Ratio	0.71	0.38	0.31	0.29	0.31	0.44
PB Ratio	0.45	0.24	0.19	0.21	0.26	0.30
P/TBV Ratio	0.47	0.25	0.19	0.22	0.27	0.31
P/FCF Ratio	3.26	1.72	1.41	1.09	1.85	2.76
P/OCF Ratio	3.19	1.69	1.39	0.99	1.79	2.69
EV/Sales Ratio	1.43	1.16	1.24	1.13	1.18	1.45
EV/EBITDA Ratio	6.23	7.40	9.23	7.06	9.54	11.31
EV/EBIT Ratio	13.53	10.98	15.80	10.04	13.52	18.40
EV/FCF Ratio	6.54	5.30	5.65	4.30	7.10	9.12
Debt / Equity Ratio	0.70	0.70	0.85	0.93	0.98	1.10
Debt / EBITDA Ratio	4.78	4.78	6.41	5.43	6.17	7.21
Debt / FCF Ratio	5.01	5.01	6.30	4.77	7.08	10.05
Asset Turnover	0.32	0.32	0.28	0.32	0.36	0.27
Inventory Turnover	1198.52	1198.52	1210.22	1526.62	954.26	316.14
Quick Ratio	0.87	0.87	0.83	0.98	0.94	0.94
Current Ratio	1.14	1.14	1.02	1.18	1.18	1.17
Return on Equity (ROE)	4.78%	4.78%	0.76%	0.25%	2.91%	1.39%
Return on Assets (ROA)	2.10%	2.10%	1.39%	2.24%	1.94%	1.34%
Return on Capital (ROIC)	2.42%	2.42%	1.58%	2.59%	2.26%	1.53%
Return on Capital Employed (ROCE)	4.60%	4.60%	3.00%	4.80%	4.20%	3.00%
Earnings Yield	7.21%	13.62%	1.39%	0.36%	14.91%	4.42%
FCF Yield	30.72%	58.06%	70.84%	91.57%	53.96%	36.27%
Dividend Yield	2.52%	4.82%	3.29%	1.48%	1.79%	1.05%
Payout Ratio	17.06%	17.06%	110.50%	571.43%	7.17%	-
Buyback Yield / Dilution	0.98%	0.98%	0.52%	0.07%	-	-
Total Shareholder Return	3.49%	5.80%	3.81%	1.55%	1.79%	1.05%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.